Trygg implementering av HPV-testing i Livmorhalsprogrammet

Kempers, J., et al., Budget Impact Analysis of National Cervical Cancer Screening Program in Denmark: Cytology with HPV triage vs.. HPV Primary Screening with

The aim of this report was to determine the cost-effectiveness of HPV vaccination includ- ing types 16/18 in 12-year-old girls alongside the existing cervical cancer screening

In order to determine whether HR-HPV E6/E7 mRNA testing more effectively predicts precancerous lesions and invasive cervical cancer than HR-HPV DNA testing, we aimed to compare

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepi- thelial neoplasia: a randomised controlled trial. Naucler P, Ryd

”European Guidelines for Quality Assurance of Cervical Cancer Screening and Diagnosis, 2nd edition” fra 2008 (Arbyn et al, 2007), og en rapport fra Norsk Forening for Klinisk

4.3 Paper 3: Sociodemographic characteristics, sexual behavior and knowledge about cervical cancer prevention as risk factors for high-risk human papillomavirus infection

Due to differences in test properties and understanding of oncogenesis of cervical cancer, studies comparing “head-to-head” DNA and mRNA tests in primary screening are

During the study period, the Norwegian Cervical Cancer Screening Programme (NCCSP) recommended delayed triage of women with minor cervical lesions with repeat cytology and HPV